Recent advances in using folate receptor 1 (FOLR1) for cancer diagnosis and treatment, with an emphasis on cancers that affect women
- Authors
- Varaganti, Pavitra; Buddolla, Viswanath; Lakshmi, Buddolla Anantha; Kim, Young -Joon
- Issue Date
- Aug-2023
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Keywords
- Folate receptors; FOLR1; FR -targeting imaging; Personalised medicine; Anticancer therapy
- Citation
- LIFE SCIENCES, v.326
- Journal Title
- LIFE SCIENCES
- Volume
- 326
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/89102
- DOI
- 10.1016/j.lfs.2023.121802
- ISSN
- 0024-3205
- Abstract
- A glycosylphosphatidylinositol (GPI)-anchored glycoprotein called the folate receptor 1 (FOLR1) facilitates the transportation of folate by mediating receptor-mediated endocytosis in response to ligand binding. While FOLR1 expression is typically restricted to the apical surfaces of the epithelium in the lung, kidney, and choroid plexus in healthy people, it is overexpressed in a number of solid tumours, including high-grade osteosarcoma, breast cancer, ovarian cancer, and non-small cell lung cancer. As a result, FOLR1 has become an attractive target for cancer detection and therapy, particularly for cancers that affect women. A number of methods have been developed to target FOLR1 in cancer therapy, including the development of FOLR1-targeted imaging agents for cancer diagnosis and the use of folate conjugates to deliver cytotoxic agents to cancer cells that overexpress FOLR1. Therefore, we focus on the most recent developments in employing FOLR1 for cancer diagnosis and treatment in this review, particularly with regard to cancers that affect women.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - IT융합대학 > 전자공학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/89102)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.